[Serum complement in patients with chronic renal insufficiency undergoing periodic hemodialysis]

Area of Science:

• Immunology
• Nephrology
• Biochemistry

Context:

• Patients with end-stage renal disease often require renal replacement therapy such as hemodialysis.
• The complement system, a crucial part of innate immunity, plays a role in various physiological and pathological processes.
• Alterations in complement activation have been implicated in the pathogenesis of kidney diseases.

Purpose:

• To investigate the complement system's activation status in patients undergoing chronic hemodialysis.
• To assess the levels of various complement fractions and the overall hemolytic complement activity (CH50).
• To explore the potential involvement of the alternate complement pathway in hemodialysis patients.

Summary:

• Serum complement fractions (C1q, C1s, C4, C3, C3a, C5, C9, C3PA, C1INH) and CH50 activity were measured in 24 patients with renal failure undergoing periodic hemodialysis.
• Findings indicated activation of the alternate complement pathway.
• Elevated levels of non-involved complement fractions were observed, suggesting dysregulation.

Impact:

• The study highlights potential complement system dysregulation in hemodialysis patients.
• Understanding these alterations may provide insights into complications associated with renal failure and hemodialysis.
• Further investigation into the mechanisms and biological implications of complement activation in this population is warranted.